Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,352 | 4,256 | 24,344 | 25,838 | 26,107 |
| Marketable Securities | 33,732 | 36,095 | 15,872 | 10,905 | 10,461 |
| Receivables | 664 | 475 | 275 | 651 | 888 |
| Inventories | 0 | 0 | 0 | 769 | 724 |
| Other current assets | 293 | 713 | 585 | 607 | 569 |
| TOTAL | $42,041 | $41,539 | $41,076 | $38,770 | $38,749 |
| Non-Current Assets | |||||
| PPE Net | 10,500 | 10,129 | 9,989 | 10,910 | 10,770 |
| Other Non-Current Assets | 97 | 50 | 56 | 60 | 503 |
| TOTAL | $10,597 | $10,179 | $10,044 | $10,970 | $11,273 |
| Total Assets | $48,751 | $48,051 | $47,660 | $45,878 | $46,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 349 | 719 | 436 | 684 | 532 |
| Accrued Expenses | 376 | 368 | 513 | 540 | 405 |
| TOTAL | $725 | $1,087 | $1,035 | $1,223 | $937 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $725 | $1,087 | $1,035 | $1,223 | $937 |
| Shareholders' Equity | |||||
| Common Shares | 67 | 67 | 67 | 67 | 67 |
| Retained earnings | 3,061 | 2,156 | 1,784 | -165 | 662 |
| TOTAL | $48,026 | $46,964 | $46,625 | $44,654 | $45,481 |
| Total Liabilities And Equity | $48,751 | $48,051 | $47,660 | $45,877 | $46,418 |